Breaking News

Drug application for Intuniv to treat adult ADHD

Shionogi has filed an application in Japan to expand the application to include adults with the disease

FDA to review Duaklir and Tudorza from Circassia

The US regulatory body has accepted for filing and review the medications intended for use in the treatment of chronic ...

Benzodiazepines associated with increased risk of Alzheimers

The Research was produced by the University of Eastern Finland and included all Finnish community dwellers with newly ...

Sartorius Stedim Biotech and Siemens: automating the biopharmaceutical industry

With Siemens now a preferred supplier, Sartorius’s product portfolio benefits from a globally standardised automation ...

New partnership provides personalised treatment options

BC Platforms and Negen partner to provide early risk assessment of common diseases with tools that help to reduce ...

Improved manufacturing efficiencies from Macsa ID

Latest integra software enables easy integration of coding and marking equipment with other key devices for improved ...

Treating chronic wounds with live biotherapeutics

Angharad Baldwin talks to Evelina Vågesjö, CEO, and Peter Frank, Drug Development Manager, of Swedish biologics company, ...

Antalis expands service with new Smart Packaging Centre

The company has opened a new Smart Packaging Centre at its head office in Coalville, UK, as part of ongoing expansion ...

Tracking technology takes centre stage at Cleanzone 2018

The cleanroom trade show on 23–24 October in Frankfurt will showcase the latest trends on access control, monitoring ...

The countdown to the Falsified Medicines Directive

The Falsified Medicines Directive (FMD) introduces harmonised measures to fight falsification, ensure that medicines ...

Brexit trade bill: Not yet

The UK has decided it will continue to be involved with the European Medicines Agency (EMA) after Brexit. Paul Brooks, ...

Investing in CHP for the chemicals and process sectors

The chemicals and process sectors are among the most energy intensive in the world, consuming huge quantities of both ...

UK clinical research post-Brexit

Dr Sheuli Porkess, Deputy Chief Scientific Officer of the ABPI here discusses the future of clinical research as the UK ...

Oxford Genetics to deliver custom CRISPR mammalian cell lines

The synthetic biology company signs major supply and licensing agreement